000 05035nam a2200385 c 4500
999 _c6435
_d6435
001 6435
003 ES-MaUEC
005 20200623134229.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 181029s2019 si a o |||| 0|eng d
020 _a9789811043581
024 7 _a10.1007/978-981-10-4358-1
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC454.4
_b.T74 2019EB
245 0 0 _aTreatment Resistance in Psychiatry :
_bRisk Factors, Biology, and Management
_cedited by Yong-Ku Kim
264 1 _aSingapore
_bSpringer Singapore :
_bImprint: Springer
_c2019.
300 _a1 recurso en línea (XV, 416 páginas 38 ilustraciones, 10 ilustraciones a color)
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 0 _aMedicine (Springer-11650)
505 0 _aPart I. Rethinking the treatment resistance in psychiatry -- Chapter 1. Definition and epidemiology of treatment resistance in psychiatry -- Chapter 2. Paradigm shift in study of treatment resistant psychiatric disorder -- Chapter 3. Genetic factors underlying treatment resistance in psychiatry -- Chapter 4. Using neuroimaging and electroencephalography for prediction of treatment resistance in psychiatric disorders -- Chapter 5. Developing therapies for treatment-resistant depressive disorders in animal models -- Chapter 6. Integrated approaches to treatment-resistant psychiatric disorders -- Part II. Treatment resistance in specific disorders -- Chapter 7. Treatment resistant depression: understandings on the neurobiological etiology that lead to novel pharmacological treatment options -- Chapter 8. Treatment Resistant Schizophrenia: assessment and management -- Chapter 9. Treatment resistance in bipolar disorders -- Chapter 10. Treatment resistance in post-traumatic stress disorder -- Chapter 11. Treatment resistance in obsessive compulsive disorder -- Chapter 12. Treatment of opioid dependence -- Chapter 13. Treatment-resistant panic disorder -- Chapter 14. Treatment resistance in anxiety disorder: generalized anxiety disorder, social anxiety disorder -- Chapter 15. Treatment resistance in Attention-Deficit Hyperactivity Disorder -- Chapter 16. Treatment resistance in Tourette syndrome -- Chapter 17. Treatment-Resistance Eating Disorders -- Chapter 18. Comorbid sleep and wake problems in treatment-resistant psychiatric conditions -- Part III. Therapeutic intervention for treatment resistance -- Chapter 19. Creative, person-centered psychopharmacology for treatment resistance in psychiatry -- Chapter 20. A psychodynamic approach to treatment resistance -- Chapter 21. Cognitive behavioral therapy and behavioral activation therapy for treatment resistant depression: traditional and digital therapy perspectives -- Chapter 22. Novel neurostimulation therapeutic approaches for treatment resistant psychiatric disorders -- Chapter 23. When clozapine fails: augmentation strategies in the management of clozapine-resistant schizophrenia -- Chapter 24. Fecal microbiota transplantation in the treatment resistant psychiatric disorders -- Chapter 25. Neurosurgical intervention for treatment-resistant psychiatric disorders.
520 3 _aThis book reviews all the important aspects of treatment-resistant psychiatric disorders, covering issues such as definitions, clinical aspects, neurobiological correlates, treatment options, and predictors of treatment response. The book is divided into three sections, the first of which examines the most recent thinking on treatment resistance in psychiatry, including definition and epidemiology, paradigm shift in the study of the subjects, individual susceptibility and resilience, abnormal structural or functional connectivity, and insights from animal models. The second section then discusses treatment resistance in each of the major psychiatric disorders, with particular focus on the responsible clinical and biological factors and the available management strategies. Finally, more detailed information is presented on diverse pharmacological and non-pharmacological therapeutic interventions. The book, written by leading experts from across the world, will be of value to all who seek a better understanding of the clinical-neurobiological underpinnings and the development of management for treatment resistance in psychiatric disorders.
988 _aPrimersemestre_2019_Medicine
650 7 _aPsiquiatría
_9139041
700 1 _aKim, Yong-Ku.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9789811043574
776 0 8 _iPrinted edition:
_z9789811043598
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-4358-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_el
_zSI